Previous Merck and Bayer Executive Accepts Full Time Role and Company Adds More Experience to Fuse Science Management Team

MIAMI LAKES, Fla., Feb. 15, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP) (www.fusescience.com), announced today that current advisory board member, Jeanne Hebert, will be accepting a full time role as Vice President of Marketing and Clinical Research, effective immediately. The Company also announced it has added Julie Zastrow to the management team to lead our grass roots marketing, athlete management and social media efforts.

(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO)

Hebert brings more than 20 years sales, marketing and research experience in the pharmaceutical and medical device industries, having worked for leading global manufacturers Bristol-Myers Squibb, Bayer Pharmaceutical, Merck & Co. and Integral Orthopedics Inc. During her career, she has provided direction on science-based content to strategic objectives for big Pharma and was a member of the Scientific Advisory Board at Merck. Hebert will be advancing product innovation through development and commercialization phases, including work with suppliers on product design and advanced medical prototyping. In her previous executive roles she has led aggressive corporate intellectual property protection efforts, better designs and web protection strategies to strengthen the company's defenses against competition.  Jeanne has designed and initiated internal and external clinical studies and provided oversight on testing of new products leading to favorable outcomes and the launch of several new products.

Over the past 18 years Julie Zastrow has held progressive marketing roles building brands. Julie was formerly Vice President of Marketing and Merchandising for TapouT Inc., the number one MMA brand within the UFC. Prior to that, Julie was head of merchandising for Champs Sports and managed athlete integration into the brand.

"We are very pleased to have Jeanne & Julie join our team," said Rubin Hanan, President and COO. "We are aggressively driving our product commercialization efforts, continued research and athlete strategy for the Powered By Fuse™ brand. The full time commitment of Ms. Herbert and Ms. Zastrow to our business brings immediate positive impact and advancement to this strategy."

Fuse Science recently launched its EnerJel™  brand with strong demand and Ms. Hebert and Ms. Zastrow will play a key role in the continued commercialization of the Powered by Fuse™  brand in all forms as the Company expands its distribution and licensing footprint in 2012.

About Fuse Science Inc.

Fuse Science Inc. (OTCQB:  DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at   www.fusescience.com  or by calling 305-503-FUSE (3873).

Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science Inc.